Financial reports
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
10-Q
2021 Q2
Quarterly report
17 Aug 21
NT 10-Q
Notice of late quarterly filing
17 Aug 21
10-Q
2021 Q1
Quarterly report
28 May 21
NT 10-Q
Notice of late quarterly filing
17 May 21
10-K
2020 FY
Annual report
15 Apr 21
NT 10-K
Notice of late annual filing
31 Mar 21
Current reports
8-K
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination
7 Mar 22
8-K
Submission of Matters to a Vote of Security Holders
22 Feb 22
8-K
Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders
18 Feb 22
8-K
Entry into a Material Definitive Agreement
17 Feb 22
8-K
Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders
15 Feb 22
8-K
The combined company will be named Alpha Tau Medical Ltd. and remain listed on the NASDAQ under ticker DRTS
19 Jan 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
15 Nov 21
8-K
Entry into a Material Definitive Agreement
8 Jul 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Jun 21
8-K
Healthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and Warrants
4 Mar 21
Registration and prospectus
15-12B
Securities registration termination
17 Mar 22
25-NSE
Exchange delisting
7 Mar 22
425
Business combination disclosure
18 Feb 22
425
Business combination disclosure
17 Feb 22
425
Business combination disclosure
15 Feb 22
425
Business combination disclosure
20 Jan 22
425
Business combination disclosure
19 Jan 22
425
Business combination disclosure
12 Jan 22
425
Business combination disclosure
10 Jan 22
425
Business combination disclosure
3 Jan 22
Other
EFFECT
Notice of effectiveness
15 Jan 21
CERT
Certification of approval for exchange listing
14 Jan 21
CORRESP
Correspondence with SEC
13 Jan 21
CORRESP
Correspondence with SEC
13 Jan 21
CORRESP
Correspondence with SEC
13 Jan 21
UPLOAD
Letter from SEC
12 Jan 21
CORRESP
Correspondence with SEC
11 Jan 21
UPLOAD
Letter from SEC
28 Dec 20
Ownership
SC 13G/A
Vellar Opportunities Fund Master, Ltd.
14 Feb 23
4
DAVID MARK MILCH
9 Mar 22
SC 13G/A
Healthcare Capital Sponsor LLC
9 Mar 22
SC 13G
Beryl Capital Management LLC
18 Feb 22
SC 13G
Healthcare Capital Sponsor LLC
14 Feb 22
SC 13G/A
Atalaya Capital Management LP
14 Feb 22
SC 13G/A
BlueCrest Capital Management Ltd
11 Feb 22
SC 13G
Weiss Asset Management LP
11 Feb 22
SC 13G/A
Linden Capital L.P.
4 Feb 22
SC 13G
Vellar Opportunities Fund Master, Ltd.
2 Feb 22